• Mettler Toledo forecasts 2026 sales of about $4.3 billion, with adjusted earnings per share of $47.80.
• Operating margin is projected at about 30%, with free cash flow of $900 million.
• The company sees opportunities to grow sales at least 6%, supported by favorable end markets and automation demand.
• Life sciences, accounting for about 40% of sales, is expected to deliver high-single-digit growth.
• Other high-growth segments generate about $250 million in sales, with double-digit growth potential.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mettler Toledo International Inc. published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.